Literature DB >> 8290432

A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.

M Ravic1, I Salas-Herrera, A Johnston, P Turner, K Foley, D E Rosenow.   

Abstract

Cimetidine 400 mg twice daily significantly increased serum concentrations and reduced apparent oral clearance of lornoxicam 8 mg twice daily in 12 healthy volunteers. Ranitidine 150 mg twice daily produced no significant changes in lornoxicam pharmacokinetics.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8290432      PMCID： PMC2399905          DOI： 10.1136/pgmj.69.817.865

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  3 in total

Review 1.  Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.

Authors:  M Ravic; A Johnston; P Turner
Journal:  Postgrad Med J       Date:  1990       Impact factor: 2.401

Review 2.  Clinical pharmacokinetic studies with lornoxicam.

Authors:  P Turner; A Johnston
Journal:  Postgrad Med J       Date:  1990       Impact factor: 2.401

3.  Chlortenoxicam pharmacokinetics in young and elderly human volunteers.

Authors:  S I Ankier; A E Brimelow; P Crome; A Johnston; S J Warrington; P Turner; H P Ferber
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401
  3 in total
  5 in total

Review 1.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 2.  Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.

Authors:  J A Balfour; A Fitton; L B Barradell
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.

Authors:  Yifan Zhang; Dafang Zhong; Dayong Si; Yingjie Guo; Xiaoyan Chen; Hui Zhou
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.

Authors:  N M Skjodt; N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.